The Ipsos survey of 1,078 adults found 24% of people would use weight-loss jabs if they were provided for free by the health ...

Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...

The FDA has added a new warning to drugs including Ozempic and Wegovy, cautioning that patients taking the drugs may be at a ...

Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration ...

This medication doesn’t have FDA approval for weight loss, but some healthcare providers prescribe Rybelsus off-label for this purpose. (Off-label use is when a drug is prescribed to treat a ...

The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...

Today it is happening again with GLP1 agonists like Semaglutide with the brand names of Wegovy, Ozempic, and Rybelsus and similar drugs like Moujaro and Zepbound. And just like all the other weight ...

and Rybelsus. Currently, only Wegovy is approved for weight loss in the United States. Semaglutide is also used to manage type 2 diabetes. The drug suppresses appetite and promotes satiety ...

A surprise amount of Brits say they would take anti-obesity drugs if they were given to them for free on the ...

Little surprise then that, this May, the health analytics company Airfinity calculated that a record 322 weight ... claim you can lose “more than two inches” (or 10 to 15 per cent of your belly fat) ...

and Rybelsus and similar drugs like Moujaro and Zepbound. And just like all the other weight loss fads and trends, people gain the weight back after they stop taking the drug. One recent study ...